Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XYXAL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DCLL9718S
|
|||||
| Synonyms |
Anti-CLL1 THIOMAB-PBD conjugate (Genentech); Anti-CLL1 THIOMAB-PBD conjugate
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.; Roche Holding AG; University of Texas MD Anderson Cancer Center
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Acute myeloid leukaemia [ICD11:2A60]
Investigative
|
|||||
| Antibody Name |
MCLL0517A
|
Antibody Info | ||||
| Antigen Name |
C-type lectin domain family 12 member A (CLEC12A)
|
Antigen Info | ||||
| Payload Name |
PBD dimer
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Cleavable disulfide
|
Linker Info | ||||
| Conjugate Type |
THIOMAB antibodydrug conjugate (TDC).
|
|||||
| TTD ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.